Get notified when NEUP files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Auditor Resignation (new) — Ernst & Young resigned as the company's independent auditor effective June 14, 2024, which can signal accounting disagreements or internal control issues.
  • Nasdaq Delisting Risk (new) — The company's ADS price has recently been below $1.00, risking delisting from Nasdaq if the minimum bid price requirement is not met.
  • Warrant Overhang (new) — The selling shareholder holds warrants to purchase up to 19,124,355 ADSs at $0.99 per ADS, creating significant potential dilution for existing holders.
  • Related Party Transaction (new) — The company paid WG Partners LLP, whose CEO is a director of Neuphoria, $89,112 in fees and a $100,000 commission related to the private placement.
NASDAQ: NEUP Neuphoria Therapeutics Inc. 424B3

Neuphoria Therapeutics files to register 233.4M shares for resale by Armistice Capital; company gets no proceeds

Filed June 26, 2024 · ~2 min read

Key Changes

  • high

    This is a secondary offering: Armistice Capital is selling up to 233,367,480 ordinary shares (9.8% of shares outstanding). Neuphoria receives no proceeds.

    The Offering verify on EDGAR →
  • high

    The company is clinical-stage with no approved products, has never generated product revenue, and expects significant losses for the foreseeable future.

    Risk Factors verify on EDGAR →
  • high

    Neuphoria depends on collaboration partners Merck and Carina Biotech to develop and commercialize its product candidates; failure by these partners could significantly harm the business.

    Risk Factors verify on EDGAR →

5 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (DBI 10-Q) is open in full — no account needed.

Partner

Trade NEUP commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify